-
Esteemed Psychedelic Researcher And Pioneer Roland Griffiths Passes Away At Age 77
Wednesday, October 18, 2023 - 10:28am | 1266Read More...A sad day in the psychedelics community today as news filters out that leading industry neuroscientist, Dr. Roland Griffiths, Ph.D., has passed. The esteemed Johns Hopkins University psychopharmacologist is described as the man who brought psilocybin back into the field of medical...
-
NIDA Partners With The National Institute Of Mental Health To Study Psychedelics Potential
Friday, May 5, 2023 - 2:49pm | 285Read More...Nora Volkow, the director of the National Institute on Drug Abuse (NIDA), said that psychedelic substances have promising potential for therapeutic uses, particularly for treating severe depression, post-traumatic stress disorder (PTSD) and addiction. Accelerating Research At a...
-
Studying Psychedelics As Medicine: UK University Offers Postgrad Course On Clinical Use
Tuesday, April 25, 2023 - 5:32pm | 205Read More...The University of Exeter is launching a new postgraduate program on psychedelics, called "Psychedelics: Mind, Medicine, and Culture." The program aims to train therapists, mental health advocates, and healthcare workers on how to safely work with psilocybin, LSD, MDMA, and other...
-
Compass Pathways Reports Q1 Financial Results, With Increased R&D Expenses Compared To 2021
Wednesday, May 11, 2022 - 10:21am | 370Read More...Compass Pathways (NASDAQ: CMPS) announced its financial results for the first quarter of 2022, which ended March 31. Q1 Results For the first three months of the year, net loss was $21.2 million, or $0.50 loss per share. For comparison, net loss in the same period of 2021 was $12.7 million or...
